/Lists

Biotech Investors & VC Firms in Global

911 firms in this list, with a median first check of $500K. 234 of them lead rounds. Generated from verified public data and updated continuously.

Blackstone Life Sciences
New YorkSeries A–Late Stage$20M – $60M
227 people
Menlo Ventures
San FranciscoPre-Seed–Late Stage$1M – $20M
55 people
Sands Capital Ventures
ArlingtonSeed–Late Stage$10M – $30M
187 people
DCVC (Data Collective)
Palo AltoPre-Seed–Growth$5M – $25M
52 people
Hercules Capital, Inc.
San MateoSeed–Late Stage
52 people
Draper Associates
San MateoPre-Seed–Series A$500K – $5M
23 people
8VC
AustinPre-Seed–Series C$500K – $50M
58 people
In-Q-Tel
WashingtonSeed–Growth$100K – $2.5M
35 people
OrbiMed
New YorkSeed–Late Stage$1M – $75M
93 people
B Capital Group
San FranciscoPre-Seed–Late Stage$10M – $50M
99 people
Deerfield Management Company
New YorkSeed–Late Stage
144 people
Saints Capital
DenverGrowth–Late Stage
22 people
True Ventures
San FranciscoPre-Seed–Series A$500K – $3M
42 people
Speedinvest
ViennaPre-Seed–Series A$5M – $30M
67 people
Cerberus Capital Management
New YorkPre-Seed–Seed
163 people
SV Health Investors
LondonSeed–Late Stage$1M – $20M
88 people
Wellington Management
BostonGrowth–Late Stage$5M – $50M
84 people
Aju IB Investment
SeoulGrowth
39 people
HongShan Capital Group
Hong KongSeed–Growth$100K – $50M
89 people
Lux Capital
New YorkPre-Seed–Series B$100K – $100M
46 people
VU Venture Partners
San FranciscoSeed–Series B$200K – $1M
116 people
Capria Ventures
SeattleSeed–Growth$300K – $1M
19 people
Blackbird Ventures
SydneyPre-Seed–Series B$149K – $60M
51 people
Frazier Life Sciences
Palo AltoSeed–Late Stage
77 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.